31000172101: Belgian Dutch language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\Belgian Dutch language reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 15-Mar 2018. Module: Belgian module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Belgian Dutch language reference set (foundation metadata concept)	Is a	Language type reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
42	Preferred (foundation metadata concept)
43	Preferred (foundation metadata concept)
44	Preferred (foundation metadata concept)
45	Preferred (foundation metadata concept)
45,X/46,XX-mozaïcisme	Acceptable (foundation metadata concept)
46,X-karyotype met afwijkend geslachtschromosoom behalve iso (Xq)	Preferred (foundation metadata concept)
46,XX geslachtsontwikkelingsstoornis, anorectale anomalieën	Preferred (foundation metadata concept)
46,XX geslachtsontwikkelingsstoornis, skeletale anomalieën	Preferred (foundation metadata concept)
46,XX ovotesticulaire DSD	Acceptable (foundation metadata concept)
46,XX ovotesticulaire geslachtsontwikkelingsstoornis	Preferred (foundation metadata concept)
46,XX-DSD	Acceptable (foundation metadata concept)
46,XX-DSD door maternaal androgeenproducerend luteoom	Acceptable (foundation metadata concept)
46,XX-DSD door maternaal arrenoblastoom	Acceptable (foundation metadata concept)
46,XX-DSD door maternale Krukenberg-tumor	Acceptable (foundation metadata concept)
46,XX-DSD door maternale bijniertumor	Acceptable (foundation metadata concept)
46,XX-DSD door oraal DES	Acceptable (foundation metadata concept)
46,XX-DSD door oraal synthetisch progestageen	Acceptable (foundation metadata concept)
46,XX-DSD door testosteron en testosteronderivaat	Acceptable (foundation metadata concept)
46,XX-DSD van testis	Acceptable (foundation metadata concept)
46,XX-geslachtsontwikkelingsstoornis	Preferred (foundation metadata concept)
46,XX-geslachtsontwikkelingsstoornis door androblastoom bij moeder	Preferred (foundation metadata concept)
46,XX-geslachtsontwikkelingsstoornis door androgeenproducerend luteoom bij moeder	Preferred (foundation metadata concept)
46,XX-geslachtsontwikkelingsstoornis door arrenoblastoom bij moeder	Acceptable (foundation metadata concept)
46,XX-geslachtsontwikkelingsstoornis door bijniertumor bij moeder	Acceptable (foundation metadata concept)
46,XX-geslachtsontwikkelingsstoornis door fibrosarcoma ovarii mucocellulare carcinomatodes bij moeder	Preferred (foundation metadata concept)
46,XX-geslachtsontwikkelingsstoornis door maternaal androgeenproducerend luteoom	Acceptable (foundation metadata concept)
46,XX-geslachtsontwikkelingsstoornis door maternale Krukenberg-tumor	Acceptable (foundation metadata concept)
46,XX-geslachtsontwikkelingsstoornis door neoplasma van bijnier bij moeder	Preferred (foundation metadata concept)
46,XX-geslachtsontwikkelingsstoornis door oraal di-ethylstilbestrol	Preferred (foundation metadata concept)
46,XX-geslachtsontwikkelingsstoornis door oraal synthetisch di-ethylstilbestrol	Acceptable (foundation metadata concept)
46,XX-geslachtsontwikkelingsstoornis door oraal synthetisch progestageen	Preferred (foundation metadata concept)
46,XX-geslachtsontwikkelingsstoornis door testosteron en testosteronderivaat	Preferred (foundation metadata concept)
46,XX-geslachtsontwikkelingsstoornis van testis	Preferred (foundation metadata concept)
46,XX-stoornis in geslachtelijke ontwikkeling	Acceptable (foundation metadata concept)
46,XX-stoornis in geslachtelijke ontwikkeling door gebruik van testosteron en testosteronderivaat	Acceptable (foundation metadata concept)
46,XX-stoornis in geslachtelijke ontwikkeling door inname van DES	Acceptable (foundation metadata concept)
46,XX-stoornis in geslachtelijke ontwikkeling door inname van synthetisch progestogeen	Acceptable (foundation metadata concept)
46,XX-stoornis van testiculaire ontwikkeling	Acceptable (foundation metadata concept)
46,XY ovotesticulaire DSD	Acceptable (foundation metadata concept)
46,XY ovotesticulaire geslachtsontwikkelingsstoornis	Preferred (foundation metadata concept)
46,XY partiële gonadale dysgenesie	Preferred (foundation metadata concept)
46,XY-DSD	Acceptable (foundation metadata concept)
46,XY-DSD door blootstelling aan chemische stoffen in omgeving	Acceptable (foundation metadata concept)
46,XY-DSD door maternale oestrogeeninname	Acceptable (foundation metadata concept)
46,XY-DSD door progestageeninname door moeder	Acceptable (foundation metadata concept)
46,XY-geslachtsontwikkelingsstoornis	Preferred (foundation metadata concept)
46,XY-geslachtsontwikkelingsstoornis door blootstelling aan chemische stoffen in omgeving	Preferred (foundation metadata concept)
46,XY-geslachtsontwikkelingsstoornis door geïsoleerde deficiëntie van 17,20-lyase	Preferred (foundation metadata concept)
46,XY-geslachtsontwikkelingsstoornis door inname van oestrogeen door moeder	Preferred (foundation metadata concept)
46,XY-geslachtsontwikkelingsstoornis door inname van progestageen door moeder	Preferred (foundation metadata concept)
46,XY-geslachtsontwikkelingsstoornis door maternale progestogeeninname	Acceptable (foundation metadata concept)
46,XY-geslachtsontwikkelingsstoornis door oestrogeeninname door moeder	Acceptable (foundation metadata concept)
46,XY-stoornis in geslachtelijke ontwikkeling	Acceptable (foundation metadata concept)
46,XY-stoornis in geslachtelijke ontwikkeling door blootstelling aan chemische omgevingsstoffen	Acceptable (foundation metadata concept)
46,XY-stoornis in geslachtelijke ontwikkeling door geïsoleerde 17,20-lyasedeficiëntie	Acceptable (foundation metadata concept)
47-kDa-eiwit van Borrelia burgdorferi	Preferred (foundation metadata concept)
48	Preferred (foundation metadata concept)
48,XYYY-syndroom	Preferred (foundation metadata concept)
48-uursfeces	Acceptable (foundation metadata concept)
48-uursurine	Preferred (foundation metadata concept)
49,XXXXX-syndroom	Acceptable (foundation metadata concept)
49,XXXXY-syndroom	Preferred (foundation metadata concept)
49,XXXYY-syndroom	Preferred (foundation metadata concept)
49,XYYYY-syndroom	Preferred (foundation metadata concept)
4D-CT ter voorbereiding op radiotherapie	Preferred (foundation metadata concept)
4D-echo	Acceptable (foundation metadata concept)
4D-echocardiografie	Acceptable (foundation metadata concept)
4H-leukodystrofie	Preferred (foundation metadata concept)
4p-deletiesyndroom	Acceptable (foundation metadata concept)
4p-syndroom	Preferred (foundation metadata concept)
4p16.3 microduplicatiesyndroom	Preferred (foundation metadata concept)
4q21 microdeletiesyndroom	Preferred (foundation metadata concept)
5	Preferred (foundation metadata concept)
5 dagen post partum	Acceptable (foundation metadata concept)
5 eerdere graviditeiten	Acceptable (foundation metadata concept)
5 eerdere zwangerschapsafbrekingen	Acceptable (foundation metadata concept)
5'-NT in serum normaal	Acceptable (foundation metadata concept)
5'-nucleotidasedeficiëntie	Acceptable (foundation metadata concept)
5,10-methyleentetrahydrofolaatreductasedeficiëntie	Acceptable (foundation metadata concept)
5-HT afwijkend	Acceptable (foundation metadata concept)
5-HT binnen normaalwaarden	Acceptable (foundation metadata concept)
5-HT-producerende NET	Acceptable (foundation metadata concept)
5-HT3-antagonist	Preferred (foundation metadata concept)
5-HT3-receptorantagonist	Acceptable (foundation metadata concept)
5-alfareductase-2-deficiëntie	Acceptable (foundation metadata concept)
5-alfareductaseremmer	Preferred (foundation metadata concept)
5-amino-4-imidazolcarboxamideribosidurie	Preferred (foundation metadata concept)
5-aminolevulinezuur	Preferred (foundation metadata concept)
5-fluorocytosine	Acceptable (foundation metadata concept)
5-hydroxytryptamine abnormaal	Acceptable (foundation metadata concept)
5-hydroxytryptamine binnen referentie-interval	Acceptable (foundation metadata concept)
5-hydroxytryptamine-3-receptorantagonist	Preferred (foundation metadata concept)
5-hydroxytryptamine-3-receptorantagonist	Acceptable (foundation metadata concept)
5-hydroxytryptamine-producerende neuro-endocriene tumor	Acceptable (foundation metadata concept)
5-lipoxygenaseremmer	Preferred (foundation metadata concept)
5-methoxypsoraleen	Preferred (foundation metadata concept)
5-oxoprolinase	Preferred (foundation metadata concept)
5-oxoprolinasedeficiëntie	Preferred (foundation metadata concept)
5-oxoproline	Preferred (foundation metadata concept)
5-uurpositie	Preferred (foundation metadata concept)
50	Preferred (foundation metadata concept)

Start Previous Page 67 of 5800 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
51000172114	Belgian Dutch language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	Belgian module (core metadata concept)
61000172111	Belgian Dutch language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	Belgian module (core metadata concept)
80681000172111	fichier de référence néerlandais belge	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Belgian module (core metadata concept)
80731000172116	Belgisch-Nederlands referentiebestand	nl	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	Belgian module (core metadata concept)